Optimization of Therapy for Severe Aplastic Anemia Based on Clinical, Biological and Treatment Response Parameters: Conclusions of an International Working Group on Severe Aplastic Anemia Convened by the Blood and Marrow Transplant Clinical Trials Network, March 2010

Although recent advances in therapy offer the promise for improving survival in patients with severe aplastic anemia (SAA), the small size of the patient population, lack of a mechanism in North America for longitudinal follow-up of patients and inadequate cooperation among hematologists, scientists...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Pulsipher, Michael A., Young, Neal S., Tolar, Jakub, Risitano, Antonio M., Deeg, H.Joachim, Anderlini, Paolo, Calado, Rodrigo, Kojima, Seiji, Eapen, Mary, Harris, Richard, Scheinberg, Phillip, Savage, Sharon, Maciejewski, Jaroslaw P., Tiu, Ramon V., DiFronzo, Nancy, Horowitz, Mary M., Antin, Joseph H.
Format: Artigo
Idioma:Inglês
Publicat: 2010
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3053041/
https://ncbi.nlm.nih.gov/pubmed/21034841
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2010.10.028
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars